Exactly what I have been complaining about for 5 months. Lack of communication from AXIM Management about sales and manufacturing and shipping.
Until AXIM Management provides a Press Release on how many locations are actually buying our products and what the reorder rate is, we will not see much change in share price until AFTER the Q2 10-Q results in August 2024.
Just my opinion.
Not investment advice.
Lots of things can change, but after so many missed promises in 2023, AXIM management lost trust even from shareholders that are focused on AXIM.
Personally the Auer Precision partnership announcement is a really big deal. Verséa Ophthalmics LinkedIn posts do provide a glimpse of hope.
However what is there for new investors to look at?? Last press release on manufacturing and sales and shipping was on July 12th. In 1 week that will be 6 months ago. The Auer Precision announcement is as big an announcement as possible before the CLIA Waivers are approved.
Just my opinion.
Not investment advice.
Good luck to everyone.
Market Data 
Markets 
AI
